FIND A PROTON CENTER
National Association for Proton Therapy National Association for Proton Therapy National Association for Proton Therapy National Association for Proton Therapy
  • ABOUT
    • About NAPT
    • Our Advocacy
    • Leadership
    • Awards
    • Corporate Partners
    • Join NAPT
  • PROTON THERAPY
    • History
    • FAQ
    • Pediatric Proton Therapy
  • FOR PATIENTS
    • Find A Proton Center
    • Patient Stories
    • Clinical Trials
    • Resource Center
  • FOR PROVIDERS
    • Clinical Research
    • Clinical Trials
  • EVENTS
  • NEWS
    • NAPT News
    • Proton Therapy In The News
National Association for Proton Therapy National Association for Proton Therapy
  • ABOUT
    • About NAPT
    • Our Advocacy
    • Leadership
    • Awards
    • Corporate Partners
    • Join NAPT
  • PROTON THERAPY
    • History
    • FAQ
    • Pediatric Proton Therapy
  • FOR PATIENTS
    • Find A Proton Center
    • Patient Stories
    • Clinical Trials
    • Resource Center
  • FOR PROVIDERS
    • Clinical Research
    • Clinical Trials
  • EVENTS
  • NEWS
    • NAPT News
    • Proton Therapy In The News
Sep 21

ASTRO 2023 Model Policy for Proton Therapy a Positive Step Forward for Cancer Patients

  • September 21, 2023

Input from NAPT critical in the formulation of revised treatment and coverage guidelines, ongoing stakeholder dialogue required for more frequent updates

 

NAPT applauds revised guidelines for proton therapy approved by the American Society for Radiation Oncology (ASTRO), which recently updated its model policy to clarify and expand the types of conditions appropriate for treatment, and – with the inclusion of additional research – more accurately depict the effectiveness of proton therapy.

“This long-overdue update reflects a growing consensus among oncology professionals and medical researchers that proton therapy is effective, safe and appropriate care for an increasing number of cancer patients who may benefit from this life-saving, life-changing treatment,” said NAPT Executive Director Jennifer Maggiore. “Thanks to ongoing, open dialogue between ASTRO and NAPT regarding model process and methodology, the stage is also set for more frequent updates that will be necessary as new data emerges.”

ASTRO model policies are developed to inform and educate commercial and government payers on appropriate clinical indications for coverage. The model policy released in May 2023 expanded on the appropriate conditions and indications for proton therapy, clarified indications for therapy based on tumor site, and updated the ICD-10 code diagnosis list – a vital coverage determination tool used by the Centers for Medicare & Medicaid Services (CMS). The revised policy also added clinical references to support expanded indications for the use of proton therapy treatment.

Updated for the first time since 2017, ASTRO’s model policy was revised with input from the NAPT Physician Advisory Committee, the Particle Therapy Cooperative Group – North America (PTCOG-NA) and the Proton Collaboration Group. Proton therapy is a life-saving cancer therapy that delivers radiation directly to a tumor, sparing nearby healthy tissue. This pinpoint accuracy has been shown across multiple disease sites to improve overall survival –by reducing life-threating toxicities, being more effective at tumor eradication, or allowing more targeted doses of radiation.

“While ASTRO’s model policy for proton therapy is a step in the right direction, it is vital that future guidelines reflect the growing amount of research and evidence regarding the effectiveness of proton therapy,” said Maggiore. “We look forward to ongoing engagement with ASTRO and NAPT members to ensure that treatment and coverage guidelines for proton therapy continue to align with the needs of cancer patients and their families.”

 

  • Facebook
  • Twitter
  • Reddit
  • Pinterest
  • Google+
  • LinkedIn
  • E-Mail

JOIN US IN BOSTON!

NEWS BY TOPIC

Advocacy Events Member News NAPT Awards NAPT News News Patient Access Patient Stories Payment Stability Pediatric Cancer Press Releases Prior Authorization Proton Therapy In The News Research RO Model State Legislation VA Access

The National Association for Proton Therapy (NAPT) and its members support cancer research and treatment innovation and are committed to raising awareness about the value of proton therapy among policymakers, insurers, caregivers and patients to ensure that this advanced treatment modality is affordable and available in communities across the country.

  • Connected Community Log In
  • Privacy Policy
  • Terms of Use

LATEST NAPT NEWS

  • Insurance Delays and Denials Impede Vital Cancer Treatment
  • The Promise of Proton Therapy: A Ray of Hope for Esophageal Cancer Patients
  • Legal Battle for Life-Saving Cancer Treatment: How One Lawyer Took on Big Insurance to Expose a Broken System
  • Coach Ron Rivera awarded Cancer Support Community’s (CSC) Founders Award, Pledges to Pay It Forward
  • Just Released: 2023 NAPT Member Survey – Executive Summary

CONTACT US

The National Association for Proton Therapy 
PO Box 7801
McLean, VA 22106

202.919.4536

© 2023 National Association for Proton Therapy (NAPT)